Use of elicitors to enhance or activate the antibiotic production in streptomyces. (17th November 2022)

• Record Type: Journal Article
• Authors: Zong, Gongli; Fu, Jiafang; Zhang, Peipei; Zhang, Wenchi; Xu, Yan; Cao, Guangxiang; Zhang, Rongzhen
• Is Part Of: Critical reviews in biotechnology. Volume 42:Number 8(2022)
• Page Start: 1260
• Page End: 1283
• Publication Date: 2022-11-17
• Subjects: Streptomyces -- elicitor activation -- antibiotic production -- novel antibiotics -- bioactive compound -- regulatory mechanism; Biotechnology -- Periodicals; Biotechnology -- Periodicals; Review Literature -- Periodicals; Public Health -- Periodicals; Environment -- Periodicals; Industry -- Periodicals; Biotechnology; Review Literature; Public Health; Environment; Industry; 660.6
• DOI: 10.1080/07388551.2021.1987856
• Languages: English
• ISSNs: 0738-8551

Abstract

Abstract: Streptomyces is the largest and most significant genus of Actinobacteria, comprising 961 species. These Gram-positive bacteria produce many versatile and important bioactive compounds; of these, antibiotics, specifically the enhancement or activation of their production, have received extensive research attention. Recently, various biotic and abiotic elicitors have been reported to modify the antibiotic metabolism of Streptomyces, which promotes the production of new antibiotics and bioactive metabolites for improvement in the yields of endogenous products. However, some elicitors that obviously contribute to secondary metabolite production have not yet received sufficient attention. In this study, we have reviewed the functions and mechanisms of chemicals, novel microbial metabolic elicitors, microbial interactions, enzymes, enzyme inhibitors, environmental factors, and novel combination methods regarding antibiotic production in Streptomyces. This review has aimed to identify potentially valuable elicitors for stimulating the production of latent antibiotics or enhancing the synthesis of subsistent antibiotics in Streptomyces . Future applications and challenges in the discovery of new antibiotics and enhancement of existing antibiotic production using elicitors are discussed.